Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis

Balqis Istiqomah Gusbela, Min Huei Hsu, Chun Feng Huang, Meng Huang Wu, Daniel C. A. Nugroho, Muhammad Solihuddin Muhtar, Christine Y. Lu, Ming Hung Teng, Jason C. Hsu

Open source

DOI: 10.1177/1759720x261466904
Published: 2026-07
Container: Therapeutic Advances in Musculoskeletal Disease
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1759720x261466904,
  title = {Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis},
  author = {Balqis Istiqomah Gusbela and Min Huei Hsu and Chun Feng Huang and Meng Huang Wu and Daniel C. A. Nugroho and Muhammad Solihuddin Muhtar and Christine Y. Lu and Ming Hung Teng and Jason C. Hsu},
  year = {2026},
  journal = {Therapeutic Advances in Musculoskeletal Disease},
  doi = {10.1177/1759720x261466904},
  url = {https://doi.org/10.1177/1759720x261466904}
}

RIS

TY  - JOUR
TI  - Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis
AU  - Balqis Istiqomah Gusbela
AU  - Min Huei Hsu
AU  - Chun Feng Huang
AU  - Meng Huang Wu
AU  - Daniel C. A. Nugroho
AU  - Muhammad Solihuddin Muhtar
AU  - Christine Y. Lu
AU  - Ming Hung Teng
AU  - Jason C. Hsu
PY  - 2026
JO  - Therapeutic Advances in Musculoskeletal Disease
DO  - 10.1177/1759720x261466904
UR  - https://doi.org/10.1177/1759720x261466904
ER  -

APA

Gusbela, B. I., Hsu, M. H., Huang, C. F., Wu, M. H., Nugroho, D. C. A., Muhtar, M. S., Lu, C. Y., Teng, M. H., & Hsu, J. C. (2026). Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x261466904

Source records

crossref · retrieved 2026-09-27T06:25:37.921Z